FDA Approves BUPRENORPHINE AND NALOXONE — Lannett Company, Inc.

Lannett Company, Inc. received approval from the FDA to manufacture a generic version of Suboxone Film, combining buprenorphine and naloxone for sublingual use. This regulatory action increases competition in the opioid dependence market, likely driving down prices and diversifying supply options for healthcare providers.